Massachusetts Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62B Buy
56,911,830
+1,038,828
+2% +$27.7M 0.54% 47
2025
Q4
$1.39B Sell
55,873,002
-1,715,658
-3% -$43.3M 0.45% 66
2025
Q3
$1.47B Sell
57,588,660
-17,885,662
-24% -$441M 0.45% 65
2025
Q2
$1.83B Buy
75,474,322
+27,964
+0% +$652K 0.58% 46
2025
Q1
$1.91B Sell
75,446,358
-1,055,880
-1% -$27.6M 0.64% 39
2024
Q4
$2.03B Buy
76,502,238
+5,350,381
+8% +$145M 0.64% 33
2024
Q3
$2.06B Sell
71,151,857
-642,199
-0.9% -$18.7M 0.62% 39
2024
Q2
$2.01B Buy
71,794,056
+2,241,609
+3% +$61.7M 0.62% 36
2024
Q1
$1.93B Buy
69,552,447
+1,046,006
+2% +$29M 0.58% 44
2023
Q4
$1.97B Buy
68,506,441
+8,298,920
+14% +$251M 0.64% 37
2023
Q3
$2B Buy
60,207,521
+5,185,453
+9% +$183M 0.7% 32
2023
Q2
$2.02B Buy
55,022,068
+984,908
+2% +$38.3M 0.66% 37
2023
Q1
$2.2B Buy
54,037,160
+4,754,795
+10% +$205M 0.75% 28
2022
Q4
$2.53B Buy
49,282,365
+7,938,347
+19% +$381M 0.88% 23
2022
Q3
$1.81B Sell
41,344,018
-913,582
-2% -$44.4M 0.68% 38
2022
Q2
$2.22B Sell
42,257,600
-1,133,519
-3% -$57.8M 0.76% 33
2022
Q1
$2.25B Buy
43,391,119
+9,537,621
+28% +$495M 0.67% 40
2021
Q4
$2B Sell
33,853,498
-109,340
-0.3% -$5.42M 0.55% 49
2021
Q3
$1.46B Sell
33,962,838
-341,198
-1% -$15.1M 0.43% 62
2021
Q2
$1.34B Sell
34,304,036
-996,075
-3% -$38.7M 0.39% 69
2021
Q1
$1.28B Sell
35,300,111
-396,070
-1% -$14.1M 0.39% 68
2020
Q4
$1.31B Sell
35,696,181
-4,548,761
-11% -$167M 0.42% 64
2020
Q3
$1.4B Sell
40,244,942
-1,484,768
-4% -$52.1M 0.51% 49
2020
Q2
$1.29B Buy
41,729,710
+412,987
+1% +$14M 0.51% 51
2020
Q1
$1.28B Sell
41,316,723
-13,303,190
-24% -$453M 0.61% 42
2019
Q4
$2.03B Sell
54,619,913
-3,403,797
-6% -$121M 0.76% 36
2019
Q3
$1.98B Sell
58,023,710
-648,604
-1% -$23.6M 0.79% 33
2019
Q2
$2.41B Sell
58,672,314
-1,128,075
-2% -$44.8M 0.98% 19
2019
Q1
$2.41B Buy
59,800,389
+466,580
+0.8% +$18.7M 1.02% 19
2018
Q4
$2.46B Sell
59,333,809
-4,046,841
-6% -$168M 1.18% 14
2018
Q3
$2.65B Sell
63,380,650
-1,842,219
-3% -$70.9M 1.09% 16
2018
Q2
$2.25B Buy
65,222,869
+169,409
+0.3% +$5.79M 0.96% 23
2018
Q1
$2.19B Buy
65,053,460
+937,105
+1% +$32.2M 0.94% 24
2017
Q4
$2.2B Sell
64,116,355
-876,552
-1% -$29.9M 0.92% 28
2017
Q3
$2.2B Buy
64,992,907
+3,861,362
+6% +$124M 0.96% 24
2017
Q2
$1.95B Buy
61,131,545
+440,375
+0.7% +$13.9M 0.86% 32
2017
Q1
$1.97B Buy
60,691,170
+11,023,702
+22% +$348M 0.92% 24
2016
Q4
$1.53B Sell
49,667,468
-3,246,631
-6% -$99.1M 0.75% 38
2016
Q3
$1.7B Buy
52,914,099
+375,716
+0.7% +$12.6M 0.83% 30
2016
Q2
$1.76B Buy
52,538,383
+982,220
+2% +$31.3M 0.88% 28
2016
Q1
$1.45B Sell
51,556,163
-4,026,134
-7% -$115M 0.75% 33
2015
Q4
$1.7B Sell
55,582,297
-3,275,325
-6% -$103M 0.91% 23
2015
Q3
$1.75B Sell
58,857,622
-5,187,562
-8% -$166M 0.98% 24
2015
Q2
$2.04B Sell
64,045,184
-810,184
-1% -$26.4M 1.04% 23
2015
Q1
$2.14B Sell
64,855,368
-5,744,893
-8% -$183M 1.08% 23
2014
Q4
$2.09B Sell
70,600,261
-13,252,896
-16% -$380M 1.06% 23
2014
Q3
$2.35B Sell
83,853,157
-4,688,993
-5% -$132M 1.24% 17
2014
Q2
$2.49B Sell
88,542,150
-1,903,581
-2% -$54.3M 1.3% 17
2014
Q1
$2.76B Buy
90,445,731
+1,133,407
+1% +$33.8M 1.51% 12
2013
Q4
$2.6B Sell
89,312,324
-1,031,793
-1% -$30M 1.46% 14
2013
Q3
$2.46B Buy
90,344,117
+173,870
+0.2% +$4.73M 1.52% 12
2013
Q2
$2.4B Buy
+90,170,247
New +$2.49B 1.62% 11

Other funds holding PFE

Massachusetts Financial Services's PFE Position: Q1 2026 in Review

Massachusetts Financial Services increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $27.7M and bringing the position to 56,911,830 shares worth $1.62B. The position accounts for 0.54% of the portfolio, ranked #47.

Massachusetts Financial Services first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.76B in Q1 2014. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Massachusetts Financial Services held 56,911,830 shares of Pfizer worth $1.62B as of Q1 2026.
  • Massachusetts Financial Services bought 1,038,828 Pfizer shares in Q1 2026, an estimated $27.7M.
  • Pfizer made up 0.54% of Massachusetts Financial Services's portfolio in Q1 2026, its #47 holding.
  • Massachusetts Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Massachusetts Financial Services's Pfizer position peaked at $2.76B in Q1 2014.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.